Article Text

Download PDFPDF
The Functional Polymorphisms on Promoter Region of Matrix Metalloproteinase-12, -13 Genes May Alter the Risk of Epithelial Ovarian Carcinoma in Chinese
  1. Yan Li, MD,
  2. Jing-Hui Jia, MSc*,
  3. Shan Kang, MD*,
  4. Xiao-Juan Zhang, MSc,
  5. Jian Zhao, MSc*,
  6. Na Wang, MSc,
  7. Rong-Miao Zhou, MSc,
  8. Dong-Lan Sun, MSc,
  9. Ya-Nan Duan, MSc and
  10. Dong-Jie Wang, MSc*
  1. * Department of Obstetrics and Gynaecology, Hebei Medical University, Fourth Hospital; and
  2. Department of Molecular Biology, Hebei Cancer Institute, Shijiazhuang, China.
  1. Address correspondence and reprint requests to Li Yan, MD, Department of Molecular Biology, Hebei Cancer Institute, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang 050011, China. E-mail: Lykx1962{at}


Backgrounds and Aims: Growing evidences indicate that single nucleotide polymorphisms (SNPs) of matrix metalloproteinases (MMPs) gene promoter may alter MMPs protein expression levels to influence malignant tumors developing and progressing. Our study was to assess the effects of the SNPs in the promoter region of MMP-12 and MMP-13 on the risk of epithelial ovarian carcinoma (EOC) developing and progressing.

Methods: MMP-12 A-82G and MMP-13 A-77G SNPs were genotyped by polymerase chain reaction-restriction fragment length polymorphism in 256 EOC patients and 329 controls.

Results: The A/G genotype frequency of MMP-12 was significantly higher in patients than in controls (7.0% vs 3.3%, P = 0.04); similarly, the frequency of MMP-12 82G allele was higher in patients too (P = 0.04). Compared with A/A genotype, A/G genotype significantly increased the risk of EOC (odds ratio, 2.19; 95% confidence interval, 1.01-4.72). Age-stratified analysis showed that individuals with A/G genotype had a higher risk in the final diagnosis aged younger than 50 years. We observed no overall association between MMP-13-77A/G polymorphism and EOC. However, an elevated positive association was observed for A/A versus G/G + A/G genotypes in mucinous ovarian cancer. Combining the analyzed 2 SNPs, the haplotype distributions in patients were not significantly different from that in controls.

Conclusion: These results suggested that the G allele of the MMP-12 82A/G polymorphism might be a risk factor for the development and progression of EOC and that the A/A genotype of MMP-13-77A/G polymorphism was associated with special pathological subtype and clinical stage in EOC at least in Chinese women.

  • Epithelial ovarian carcinoma
  • MMP-12
  • MMP-13
  • Single nucleotide polymorphism
  • Risk

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare that they have no competing interests.